That’s a lot of hands this data has to pass betw
Post# of 36537
(Total Views: 259)
Posted On: 02/19/2021 6:54:04 PM
Re: skipper1072 #26718
That’s a lot of hands this data has to pass between. It will definitely take a several weeks .. it would be nice to get some interim results... but probably won’t happen. On the upside... VERY happy to see pediatric reviews involved ! If this gets a green light for pediatric trials that puts us in the mix with big pharma! Also,nice to see Joe lined up such a comprehensive review process ... if we get through this it should be “All systems go!”
Don’t expect any news next couple week please ... this is being done in a thorough and professional manner ... let the process play out. Keep in mind that traditional vaccines take several years to develop... and while mRNA vaccines took several months ... GNBT/NGIO will have a vaccine in a 1 year timeframe ... WITHOUT the federal governments help! China knows this and recognizes the value of this platform. mRNA vaccines will go on the scrap heap of technology. This is a major kudos for the technology and the management at GNBT/NGIO.
Don’t expect any news next couple week please ... this is being done in a thorough and professional manner ... let the process play out. Keep in mind that traditional vaccines take several years to develop... and while mRNA vaccines took several months ... GNBT/NGIO will have a vaccine in a 1 year timeframe ... WITHOUT the federal governments help! China knows this and recognizes the value of this platform. mRNA vaccines will go on the scrap heap of technology. This is a major kudos for the technology and the management at GNBT/NGIO.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼